American Journal of Psychiatry

Article	Citations
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features	376
Translational Mechanistic Biomarkers for the 21st Century	331
Reports to the Membership	277
Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence	152
Reviewers for The American Journal of Psychiatry	147
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans	145
Psychedelics as Transformative Therapeutics	137
Dismantling Structural Racism in Academic Psychiatry to Achieve Workforce Diversity	126
Polygenic Scores in Psychiatry: On the Road From Discovery to Implementation	124
Opioid Use Disorder: Pernicious and Persistent	99
Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction	98
The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study	98
“Closing the Loop” With Transcranial Electrical Stimulation for Depression	85
rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches	82
Association Between Intrauterine System Hormone Dosage and Depression Risk	77
COVID-19 and Stress-Related Disorders	73
Psychiatrist Burnout	71
Anterior Insula–Associated Social Novelty Recognition: Pivotal Roles of a Local Retinoic Acid Cascade and Oxytocin Signaling	69
Structural Racism and the Imperative to Eliminate Mental Health Disparities	69
Correction to Gray et al.	68
Can You Feel the Burn? Using Neuroimaging to Illuminate the Mechanisms of Mindfulness Interventions for Pain	68
APA Council Reports	68
Update to Editors’ Disclosures	67
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	67
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia	66

The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study	63
Perinatal Mental Health: Advances and Opportunities	61
Behavior as Physiology: How Dynamical-Systems Theory Could Advance Psychiatry	58
From Soldier’s Heart to Shared Genetic Risk: PTSD and Cardiovascular Disease	58
Neural Substrates of Vulnerability to Anxiety in Response to Stressful Life Events: A COVID-19 Study	57
Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services	57
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial	57
Hitting the Target of Image-Guided Psychiatry?	56
Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder	55
Antidepressants and Bipolar Disorder: The Plot Thickens	52
A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD	52
Psychiatrist Burnout: Response to Schonfeld and Bianchi	52
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	51
2022 Annual Meeting: President-Elect Address	49
The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)	49
Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention	49
Using the Power of a Giant Wisely: Confirming Inflammation in Depression	47
2024 Annual Meeting: Presidential Address	47
Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis	47
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	47
Treating Pathologies of the Will	46
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	46
Improving Treatment Outcomes Includes Increasing the Diversity of the Psychiatric Workforce	45
The American Journal of Psychiatry’s Efforts Toward Eliminating Racism, Social Injustice, Health Care Inequities, and Publication Biases	44
Mental Health Disparities Research: An Introduction to New Directions	44
Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids	44
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)	43
The Invisible Children: Is the Glass Half Full or Half Empty?	43
Highlights From the Residents’ Journal: June 2023	43
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?	42
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013	42
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	42
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	42
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	41
Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders	41
Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019	41
Neuroimaging Biomarkers in Schizophrenia	40
Neurobiological Correlates of Change in Adaptive Behavior in Autism	40
Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul	40
Optimizing the Treatment of Late-Life Depression	39
Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis	38
Predictors of Suicide Attempt Within 30 Days After First Medically Documented Suicidal Ideation in U.S. Army Soldiers	37
Developmental Pathways and Clinical Outcomes of Early Childhood Psychotic Experiences in Preadolescent Children at Familial High Risk of Schizophrenia or Bipolar Disorder: A Prospective, Longitudinal	37
Correction to Krakowski et al.	37
Intentional Drug Overdose Deaths in the United States	37
Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders	36
The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation	36
Evaluating Associations Between Cannabis and Heroin Use	35
Ubiquitous Dopamine Deficit Hypotheses in Cocaine Use Disorder Lack Support	35
Highlights From the Residents’ Journal: December 2021	35

ADHD and ASD: Time to Split or Lump?	35
Broadening the Parameters of Clinical High Risk for Psychosis	34
Race-Related Disparities in Childhood Adversity, Trauma, and Stress-Related Psychopathology	34
Growing Up With ADHD Symptoms: Smooth Transitions or a Bumpy Course?	34
Electroconvulsive Therapy in Mania: A Review of 80 Years of Clinical Experience	33
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	33
Looking Through a Fog: What Persistent Derealization Can Teach Us About PTSD	33
Scientific Advances Supporting New and Improved Treatment Strategies in Psychiatry	32
Is Poorly Assisted Psilocybin Treatment an Increasing Risk?	31
The Prehistory of Psychiatric Genetics: 1780–1910	31
Functional Connectome Prediction of Anxiety Related to the COVID-19 Pandemic	31
Vaccines as Immunotherapies for Substance Use Disorders	30
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	29
Older Adults are at Heightened Risk of the Effects of Cannabis Use	29
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia	29
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	28
Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment	28
Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits	28
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	28
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research	27
Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps	27
Toward Translatable Biomarkers of Psychedelic-Induced Neuroplasticity	27
Subcortical Brain Alterations in Carriers of Genomic Copy Number Variants	26
Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain: A Cerebral Organoid Study	26
Association of Cortico-Striatal Engagement During Cue Reactivity, Reappraisal, and Savoring of Drug and Non-Drug Stimuli With Craving in Heroin Addiction	26
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?	26
Functional Neuroimaging in PTSD: From Discovery of Underlying Mechanisms to Addressing Diagnostic Heterogeneity	25
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	25
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration	25
Racial Disparities in Adversity During Childhood and the False Appearance of Race-Related Differences in Brain Structure	25
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial	25
Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments	25
Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study	24
Association of Inflammatory Activity With Larger Neural Responses to Threat and Reward Among Children Living in Poverty	24
Translational Neuroscience Approaches to Understanding Autism	24
Disrupted Dorsal Mid-Insula Activation During Interoception Across Psychiatric Disorders	24
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects	24
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia	24
Anxiety, Depression, and Suicide in Youth	23
Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study	23
Childhood Maltreatment and Mental Health Problems: A Systematic Review and Meta-Analysis of Quasi-Experimental Studies	22
When You Don’t Feel Right Inside: Homeostatic Dysregulation and the Mid-Insular Cortex in Psychiatric Disorders	22
Persistent Dissociation and Its Neural Correlates in Predicting Outcomes After Trauma Exposure	22
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape	22
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry	22
Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition	22
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts	22
Predictors of Substance Use Initiation by Early Adolescence	21
Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population	21
Psychotropic Drug–Related Weight Gain and Its Treatment	21
Depression: Factors Contributing to Risk and Therapeutic Insights	21
Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial	21
Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress	21
Correction to Deligiannidis et al.	20
More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan	20
Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity	20
PTSD, Phobias, Suicide Attempts, and Psychiatric Vulnerabilities	20
Mood Disorders and Outcomes of COVID-19 Hospitalizations	20
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials	20
The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder	19
Replicating Predictive Cluster-Based Imaging Biotypes After Trauma: A Bridge Too Far?	19
Highlights From the Residents’ Journal: June 2022	19
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder	19
Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling?	18
Is Violent Suicide Molecularly Distinct?	18
Early-Onset Psychosis and Autism Spectrum Disorder: Similar Rates of Deleterious Copy Number Variants, Yet Diverse Phenotypic Manifestations	18
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	18
Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia	18
An Insula-Enriched Regulator of Retinoic Acid Marks a New Intersection in the Neural Circuitry of Mouse Social Behavior	18
Focusing on Substance Use Disorders, Opioids, and Craving	18
Treatments for Depression in Bipolar II Disorder	18
The Intergenerational Transmission of Anxiety Disorders and Major Depression	18
Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Inve	18
Comment on “Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids”	17
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	17
Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits	17
Understanding the Value and Limitations of MRI Neuroimaging in Psychiatry	17
Suicide and the Menstrual Cycle	17
Applying Functional Imaging to Clinical Practice: Are We Making Progress Toward Its Promise?	17
Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences	17

Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia	16
Subcortical Anatomy in Neurogenetic Disorders: New Findings and Future Questions	16
The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons	16
Putting Genetics to Work in the Psychiatric Clinic	16
A Comprehensive Multilevel Analysis of the Bucharest Early Intervention Project: Causal Effects on Recovery From Early Severe Deprivation	16
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents	16
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	15
Correction to Poirot et al.	15
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in Rats	15
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research	15
Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial	15
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	15
The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study	15
Neurodevelopmental and Neurodegenerative Illnesses: Autism, Fragile X Syndrome, Parkinson’s Disease, and Dementia	15
Correction to Webb et al.	15
Corrigendum to Morley et al.	15
One Small Step for PMDD, One Large Step for Affective Disorders	15